featured-image

( MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C.

, a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of against Elanco Animal health Incorporated (NYSE: ELAN), Edwards Lifesciences Corp (NYSE: EW), and United Parcel Service, Inc. (NYSE: UPS). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.



Additional information about each case can be found at the link provided. Elanco Animal Health Incorporated (NYSE: ELAN) Class Period: November 7, 2023 - June 26, 2024 Lead Plaintiff Deadline: December 6, 2024 The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) Zenrelia was less safe than the Company had led investors to believe; (2) Elanco was unlikely to meet its own previously issued timeline for the U.

S. approval and commercial launch of both Zenrelia and Credelio Quattro; (3) accordingly, the Company's business and/or financial prospects were overstated; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times. For more information on the Elanco class action go to: Edwards Lifesciences Corp (NYSE: .

Back to Health Page